FDA Inspection
Appco Pharma LLCAppco Pharma LLC – FDA Inspection, Mar 11, 2024
Record Details
This FDA Inspection record concerns Appco Pharma LLC, with an inspection on March 11, 2024, issued by the Center for Drug Evaluation and Research.
- Company
- Appco Pharma LLC
- Inspection Date
- March 11, 2024
View Company Profile
ID · b847f1fe-c466-48a8-8cad-d077d6a1104d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1232512
- FDA center
- Human Drugs
- Project area
- Postmarket Surv. and Epidemiology
FDA Citations
2- 21 CFR 314.80(c)(1)(ii)Failure to investigate serious, unexpected events
- 21 CFR 314.80(b)Failure to develop written procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Appco Pharma LLC
9| Date | Classification | Office | Project area |
|---|---|---|---|
| May 14, 2026 | Not classified | New Jersey District Office | Drug Quality Assurance |
| August 29, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 19, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 27, 2020 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 28, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Appco Pharma LLC
- FDA Inspection 1301504 - 2026-05-14
- FDA Inspection 1216223 - 2023-08-29
- FDA Inspection 1179037 - 2022-08-19
- FDA Inspection 1122406 - 2020-03-27
- FDA Inspection 1093238 - 2019-05-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.